BIIB | Guidance
Journal Entry
Bias: Positive.
Sentiment: Optimistic.
Emoji (emotion): Speculative 🧙♂️.
Null Hypothesis: Buy.
Alternative Hypothesis: Sell, Buy then Sell.
Signals: ...
Position: Day/Swing trade.
Notes: I'm anticipating the market to buy the earnings surprise 07/20/22 BMO: https://www.estimize.com/biib/fq2-2022?metric_name=eps&chart=historical
Barron's Company Overview: https://www.barrons.com/market-data/stocks/biib?mod=searchresults_companyquotes&mod=searchbar.
Other: ...
Tutorial: (Q/A) What exactly is the box labeled tolerance? The box labeled tolerance is a defined range of value & time that qualifies the right to exit the trade after a profit is made; as long as the security is inside the box and above the trade's entry one could say the profit is within tolerance, likewise if the security is outside the box either because of value or time one could say the profit is not within tolerance. It's a way to add parameters to the future outcome of the journal entry (as a means to grade the journal entry) while simultaneously providing leniency in the ability to achieve success with said journal entry.
About the Security: "Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA."
About the Author: I'm happy to hear from my readers/audience and I encourage constructive feedback, although I'm busy I will give my best effort to reply; please don't get discouraged if I don't reply because your comment is still open for discussion with the rest of the Tradingview community. Some of my goals include building an esteemed reputation, attracting a prolific following, ranking as a Top Author, and earning the Tradingview Wizard badge. Apart from Tradingview I consider myself a financial scientist and the work I offer to the community as contributions apart of my open journal/goodwill to mankind.
Disclaimer: My journal entry is not a complete prospectus, please consider it accordingly.
Bias: Positive.
Sentiment: Optimistic.
Emoji (emotion): Speculative 🧙♂️.
Null Hypothesis: Buy.
Alternative Hypothesis: Sell, Buy then Sell.
Signals: ...
Position: Day/Swing trade.
Notes: I'm anticipating the market to buy the earnings surprise 07/20/22 BMO: https://www.estimize.com/biib/fq2-2022?metric_name=eps&chart=historical
Barron's Company Overview: https://www.barrons.com/market-data/stocks/biib?mod=searchresults_companyquotes&mod=searchbar.
Other: ...
Tutorial: (Q/A) What exactly is the box labeled tolerance? The box labeled tolerance is a defined range of value & time that qualifies the right to exit the trade after a profit is made; as long as the security is inside the box and above the trade's entry one could say the profit is within tolerance, likewise if the security is outside the box either because of value or time one could say the profit is not within tolerance. It's a way to add parameters to the future outcome of the journal entry (as a means to grade the journal entry) while simultaneously providing leniency in the ability to achieve success with said journal entry.
About the Security: "Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA."
About the Author: I'm happy to hear from my readers/audience and I encourage constructive feedback, although I'm busy I will give my best effort to reply; please don't get discouraged if I don't reply because your comment is still open for discussion with the rest of the Tradingview community. Some of my goals include building an esteemed reputation, attracting a prolific following, ranking as a Top Author, and earning the Tradingview Wizard badge. Apart from Tradingview I consider myself a financial scientist and the work I offer to the community as contributions apart of my open journal/goodwill to mankind.
Disclaimer: My journal entry is not a complete prospectus, please consider it accordingly.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.